PHARMALIX LIFESCIENCES PRIVATE LIMITED
PHARMALIX LIFESCIENCES PRIVATE LIMITED is a MADHYA PRADESH based PRIVATE LIMITED company, Registered at dated 04-SEP-2024 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of PHARMALIX LIFESCIENCES PRIVATE LIMITED is U21001MP2024PTC072809 and registration number is 072809.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies ROC GWALIOR India. Authorized share capital of PHARMALIX LIFESCIENCES PRIVATE LIMITED is Rs. 1500000 and its paid up capital is Rs. 750000. It aspire to serve in NA activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
PHARMALIX LIFESCIENCES PRIVATE LIMITED has 2 directors CHHATRAPAL SINGH PATEL, SURENDRA KUMAR CHATURESH,
The registered Email address of PHARMALIX LIFESCIENCES PRIVATE LIMITED is chhatrapalpatel@yahoo.com and its registered address is 648/5 INDUSTRIES AREA, RAJSHAHI, RAU, RANGWASA MHOW INDORE MP 453331 IN MADHYA PRADESH MADHYA PRADESH india 453331.
The current status of PHARMALIX LIFESCIENCES PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
PHARMALIX LIFESCIENCES PRIVATE LIMITED
ROC GWALIOR
ACTIVE
U21001MP2024PTC072809
04-SEP-2024
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
1500000
750000
CONTACT DETAILS
453331
INDIA
648/5 INDUSTRIES AREA, RAJSHAHI, RAU, RANGWASA MHOW INDORE MP 453331 IN
chhatrapalpatel@yahoo.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
09426880 | CHHATRAPAL SINGH PATEL | Director | 04/09/2024 |
10767215 | SURENDRA KUMAR CHATURESH | Director | 04/09/2024 |
Details Updated by Companies
Quick Links
- All Registered company of MADHYA PRADESH
- Company Registered in MADHYA PRADESH
- All Registered company of INDORE in MADHYA PRADESH
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.